JPMorgan Chase & Co. Raises Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $475.00
[ad_1] JPMorgan Chase & Co. raised their target price on Alnylam Pharmaceuticals from $348.00 to $475.00 and gave the stock…
[ad_1] JPMorgan Chase & Co. raised their target price on Alnylam Pharmaceuticals from $348.00 to $475.00 and gave the stock…
[ad_1] The company beat revenue expectations by a wide margin, with a CEO saying that businesses large and small are…
[ad_1] PayPal’s (PYPL) second-quarter results checked all the right boxes on paper. Growth came in stronger than expected, and Venmo…
[ad_1] Texas Roadhouse on Thursday evening reported mixed second-quarter results as elevated beef prices weighed on profitability. Still, the company…
[ad_1] Bank of Japan July meeting ‘Summary of Opinions’. At this meeting the Bank left its short term rate unchanged…
[ad_1] Tesla’s vice president of hardware design engineering, Pete Bannon, is leaving the company after first joining in 2016 from…
[ad_1] Of course, it really doesn’t matter how you compare to the average person. What really matters is whether you’re…
[ad_1] To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated…
[ad_1] Measuring corporate impact is time-consuming and resource intensive. Until recently, I worked at UN PRI and witnessed first-hand the…
[ad_1] Disney Scores Earnings Beat and 2 Big ESPN Deals [ad_2] Source link